A 7409 New York Assembly · 2025 Regular Session

Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists

Summary
Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 25, 2025 Last action Jan 7, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
2
Jan 7, 2026
Committee
REFERRED TO HEALTH
lower
Mar 25, 2025
Committee
REFERRED TO HEALTH
lower
1 primary · 0 co-sponsors

Sponsors